bictegravir (Biktarvy) Report issue

Small molecule Orphan Drug FDA Approved FDA Priority Review FDA
AACT DrugBank PubChem

Back

Chemistry

Mol. Mass

449.39

ALogP

1.63

Rule of 5

Yes

Rule of 3

No
Details
  • SMILES: OC1=C2N(C[C@H]3O[C@@H]4CC[C@@H](C4)N3C2=O)C=C(C(=O)NCc5c(F)cc(F)cc5F)C1=O
  • InChIKey: SOLUWJRYJLAZCX-LYOVBCGYSA-N
    InChI=1S/C21H18F3N3O5/c22-9-3-14(23)12(15(24)4-9)6-25-20(30)13-7-26-8-16-27(10-1-2-11(5-10)32-16)21(31)17(26)19(29)18(13)28/h3-4,7,10-11,16,29H,1-2,5-6,8H2,(H,25,30)/t10-,11+,16+/m0/s1
  • Chirality: Single Stereoisomer
  • Inorganic: No
  • Polymer: No

Sources

CHEMBL3989866   ChEMBL
bictegravir *

8GB79LOJ07   NCATS
bictegravir *

Bictegravir   Wikipedia

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue